Regenerative Medicine Advanced Therapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
INAB | F | IN8bio, Inc. | 2.49 | |
PROK | F | ProKidney Corp. | -3.52 | |
HUMA | D | Humacyte, Inc. | 3.55 | |
LCTX | D | Lineage Cell Therapeutics, Inc. | 3.02 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Regenerative Medicine Advanced Therapy stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CBLS | B | Changebridge Capital Long/Short Equity ETF | 1.97 | |
CBSE | B | Changebridge Capital Sustainable Equity ETF | 1.49 | |
XBI | D | SPDR S&P Biotech ETF | 0.19 | |
IWC | C | iShares Microcap ETF | 0.16 | |
LABU | D | Direxion Daily S&P Biotech Bull 3X Shares | 0.14 |
Compare ETFs
Related Industries:
Biotechnology
- Regenerative Medicine Advanced Therapy
Regenerative Medicine Advanced Therapy (RMAT) is a designation given by the Food and Drug Administration to drug candidates intended to treat serious or life-threatening conditions under the 21st Century Cures Act. A RMAT designation allows for accelerated approval based surrogate or intermediate endpoints.RMAT goes beyond breakthrough therapy features by allowing for accelerated approval of drugs based on surrogate endpoints. A surrogate endpoint is a biomarker that substitutes for a direct endpoint, such as clinical benefit.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles